Beta Drugs fundamental analysis
BETA
1554
36.30 (-2.28%)Last updated on 26 Dec, 2025 | 15:29 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Beta Drugs Fundamentals
P/E Ratio
36.99
P/B Ratio
7.96
Div. Yield
0
Sector P/E
70.41
Sector P/B
0.98
Sec. Div. Yield
0.56
Beta Drugs Fundamentals is currently trading with a P/E Ratio of 36.99, compared to the sector average of 70.41. Its P/B Ratio stands at 7.96, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.
Beta Drugs Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Beta Drugs reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
